Inflammatory Bowel Disease

Inflammatory bowel disease (IBD) is the collective term for chronic, relapsing inflammatory disorders of the gastrointestinal tract, principally Crohn's disease and ulcerative colitis. The conditions cause recurring symptoms such as diarrhoea, abdominal pain, rectal bleeding, and fatigue, often punctuated by flares and remissions, and they may have effects beyond the gut. Because IBD usually begins in young adulthood and persists for life, it is an important long-term topic in medical-surgical nursing.

Definition

Inflammatory bowel disease comprises chronic immune-mediated inflammatory disorders of the gut, chiefly Crohn's disease, which can affect any part of the digestive tract in a discontinuous, transmural pattern, and ulcerative colitis, which involves continuous mucosal inflammation of the colon and rectum.

Scope

The entry covers the definitions, mechanisms, presentation, and management context of Crohn's disease and ulcerative colitis as a reference subject for nursing. It addresses the relapsing-remitting course, the distinction between the two main forms, extraintestinal involvement, and the multidisciplinary management framework, without giving individualised drug dosing or treatment instructions.

Core questions

• How do Crohn's disease and ulcerative colitis differ in distribution and depth of inflammation?
• How does the relapsing-remitting course of IBD present and progress?
• What extraintestinal manifestations and complications can accompany IBD?
• How is care coordinated across gastroenterology, surgery, nursing, and dietetics over the lifespan?

Key concepts

• Crohn's disease versus ulcerative colitis
• Transmural versus mucosal inflammation
• Relapse and remission
• Extraintestinal manifestations
• Immune-mediated chronic inflammation
• Complications (strictures, fistulae, dysplasia)
• Multidisciplinary IBD care

Mechanisms

Inflammatory bowel disease is understood as a chronic, immune-mediated inflammation that arises from an interaction between genetic susceptibility, the gut microbiota, environmental factors, and a dysregulated mucosal immune response. In Crohn's disease the inflammation is typically transmural and can affect any segment of the gastrointestinal tract in a discontinuous pattern, predisposing to strictures and fistulae (Torres et al., 2017). In ulcerative colitis the inflammation is confined to the mucosa and extends continuously from the rectum proximally through the colon (Ungaro et al., 2017). The relapsing-remitting course reflects fluctuating inflammatory activity, and treatment is aimed at inducing and maintaining remission.

Clinical relevance

IBD imposes a substantial symptom and quality-of-life burden, requires long-term monitoring, and can lead to hospitalisation, surgery, and an increased risk of colorectal dysplasia in extensive colitis. Recognising flares, complications, and extraintestinal manifestations supports timely escalation and coordinated care; this entry describes the disorders for reference and is not a basis for individual diagnostic or treatment decisions.

Epidemiology

IBD has its highest prevalence in North America and Europe, and its incidence has been rising in newly industrialised regions across Asia, Africa, and South America, making it an increasingly global disease. It commonly presents in adolescence and young adulthood, though it can begin at any age, and consensus guidelines describe management pathways across the disease course (Lamb et al., 2019; Rubin et al., 2019).

Seminal works

• ungaro-2017
• torres-2017
• lamb-2019-ibd

Frequently asked questions

What are the two main types of inflammatory bowel disease?

The two principal types are Crohn's disease, which can affect any part of the digestive tract with transmural, patchy inflammation, and ulcerative colitis, which involves continuous mucosal inflammation limited to the colon and rectum.

Is inflammatory bowel disease the same as irritable bowel syndrome?

No. Inflammatory bowel disease involves chronic, immune-mediated inflammation and visible damage to the bowel, whereas irritable bowel syndrome is a functional disorder without such inflammation, although the two can share symptoms such as abdominal pain and altered bowel habit.